Latest News for: igc

Edit

IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Trial Site at Integrative Clinical ...

Image Corsicana Daily Sun 23 Jan 2026
- Multi-Specialty CNS Research Center Strengthens Trial Execution and Patient Diversity in Alzheimer's Agitation Study - ....
Edit

Statement of Changes in Beneficial Ownership (Form 4) (IGC Pharma Inc)

Public Technologies 20 Jan 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue ... See Instruction 10 ... IGC Pharma, Inc. [IGC] 5 ... (2) Each restricted stock unit represents a right to receive one share of IGC common stock ... IGC Pharma Inc.
Edit

IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Site at Dominion Medical Associates, a Lightship network site, in Richmond, Virginia (IGC Pharma Inc)

Public Technologies 12 Jan 2026
). The text version of this document is not available ... IGC Pharma Inc.
Edit

IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Site at Dominion Medical Associates, ...

Image Hastings Tribune 12 Jan 2026
- Hybrid Trial Model Enhances Participant Access, Retention, and Enrollment Efficiency Across Underserved and Rural Communities - ... .
Edit

IGC Pharma Aligns Fiscal Year with Calendar Year to Enhance U.S. Investor Transparency and Comparability

Image The Galveston Daily News 06 Jan 2026
("IGC Pharma," "IGC," or the "Company") (NYSE ...
Edit

Material Agreement (Form 8-K) (IGC Pharma Inc)

Public Technologies 06 Jan 2026
On January 5, 2026, IGC Pharma, Inc. ("IGC" or the "Company") entered into a Subscription Agreement (the "2025 Subscription Agreement") with certain ... IGC Pharma Inc.
Edit

Supplemental Prospectus (Form 424B5) (IGC Pharma Inc)

Public Technologies 06 Jan 2026
IGC Pharma, Inc ... Our Common Stock is traded on NYSE American under the symbol "IGC." On January 2, 2026, the last reported sale price of our common stock on NYSE American was $0.29 per share ... About IGC Pharma ... Stock symbol "IGC".
Edit

IGC Pharma Raises Capital to Advance IGC-AD1 Phase 2 Trial

Image Corsicana Daily Sun 05 Jan 2026
- New Financing Supports Disciplined Clinical Execution and Value Creation in Alzheimer's Drug Development - ....
Edit

Amendments to Bylaws (Form 8-K) (IGC Pharma Inc)

Public Technologies 02 Jan 2026
) ... On December 30, 2025, the Board of Directors (the "Board") of IGC Pharma, Inc ... The fiscal year change will be effective on December 31, 2025 ... IGC Pharma Inc.
Edit

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the “Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75.” (IGC Pharma Inc)

Public Technologies 31 Dec 2025
). The text version of this document is not available ... IGC Pharma Inc.
Edit

IGC Pharma Secures New U.S. Patent as Pharmaceutical Cannabinoids Gain Regulatory Momentum

Image Weatherford Democrat 20 Dec 2025
- New Patent Expands IGC Pharma's Pharmaceutical Cannabinoid Portfolio Beyond Alzheimer's Disease - ....
Edit

IGC Pharma Positions as a Singular Beneficiary of Emerging Federal Momentum Toward Schedule III Cannabinoid Medicines

Image Rutland Herald 15 Dec 2025
(NYSE American.IGC) ("IGC" or the "Company"), a ...
Edit

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We ...

Image Weatherford Democrat 11 Dec 2025
(NYSE American.IGC) ("IGC" or the "Company"), a ...
Edit

IGC scores well in customer satisfaction

Image Idaho Press-Tribune 09 Dec 2025
For the third consecutive year, Intermountain Gas Company received the highest customer satisfaction ranking among midsize residential natural gas utilities in the Western United States ... .
Edit

IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial

Image Hastings Tribune 09 Dec 2025
(NYSE American.IGC) ("IGC" or the "Company"), a ...

Article Search

tools
×
×
×
×